Related Experiment Video
Updated: Feb 27, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
The hormetic functions of Wnt pathways in tubular injury
Elisabeth F Gröne1, Giuseppina Federico1, Peter J Nelson2
1Department of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Abstract:
Chronic tubulointerstitial damage with tubular epithelial atrophy and interstitial fibrosis is the hallmark of chronic kidney disease (CKD) and a predictor for progression of CKD.Several experiments have now provided evidence that the Wnt signaling pathways are significantly contributing to atrophy and fibrosis; in contrast, it also has been shown that the Wnt system fosters regenerative processes in acute tubular injury.We now have demonstrated that Dickkopf 3 (DKK3) is an agonist for canonical Wnt signaling in CKD and fosters chronic fibrosing inflammation of the tubulointerstitial compartment. Genetic- and antibody-mediated inhibition of DKK3 leads to a pronounced improvement of tubular differentiation and a reduction in fibrosis.In addition, the secreted glycoprotein DKK3 can be used as a non-invasive urinary marker for the extent of CKD in man.
Insights
Dickkopf 3 (DKK3) drives chronic kidney disease (CKD) progression by promoting fibrosis. Inhibiting DKK3 improved kidney function and reduced fibrosis, highlighting DKK3 as a potential therapeutic target and urinary biomarker for CKD.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Chronic kidney disease (CKD) is characterized by tubulointerstitial damage, tubular atrophy, and fibrosis, which predict disease progression.
- Wnt signaling pathways are implicated in both the fibrosis of CKD and the regeneration following acute kidney injury.
- The dual role of Wnt signaling necessitates a deeper understanding of its specific mediators in chronic fibrotic kidney disease.
Purpose of the Study:
- To investigate the role of Dickkopf 3 (DKK3) in the pathogenesis of chronic kidney disease (CKD).
- To determine if DKK3 acts as an agonist for Wnt signaling in the context of CKD-associated tubulointerstitial fibrosis.
- To evaluate the therapeutic potential of inhibiting DKK3 and its utility as a non-invasive biomarker for CKD.
Main Methods:
- Utilized genetic and antibody-mediated inhibition strategies to block Dickkopf 3 (DKK3) activity in experimental models of CKD.
- Assessed the impact of DKK3 inhibition on tubular epithelial differentiation and interstitial fibrosis.
- Analyzed urinary DKK3 levels as a potential non-invasive biomarker for the extent of CKD in human patients.
Main Results:
- Demonstrated that Dickkopf 3 (DKK3) acts as an agonist for canonical Wnt signaling in chronic kidney disease (CKD).
- Showed that DKK3 promotes chronic fibrosing inflammation within the tubulointerstitial compartment.
- Confirmed that genetic and antibody-mediated inhibition of DKK3 significantly improves tubular differentiation and reduces renal fibrosis.
- Validated urinary DKK3 as a non-invasive biomarker correlating with the extent of CKD in humans.
Conclusions:
- Dickkopf 3 (DKK3) is a key driver of fibrosing inflammation and tubular atrophy in chronic kidney disease (CKD).
- Inhibition of DKK3 offers a promising therapeutic strategy for mitigating CKD progression and improving kidney structure.
- Urinary Dickkopf 3 (DKK3) represents a valuable non-invasive biomarker for assessing CKD severity.
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Regulation of Angiogenesis and Blood Supply

